Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Amortizatization of Intangibles: 2018-2024

Historic Amortizatization of Intangibles for Dianthus Therapeutics (DNTH) over the last 7 years, with Dec 2024 value amounting to $6.0 million.

  • Dianthus Therapeutics' Amortizatization of Intangibles fell 1.28% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 111.27%. This contributed to the annual value of $6.0 million for FY2024, which is 322.91% up from last year.
  • Latest data reveals that Dianthus Therapeutics reported Amortizatization of Intangibles of $6.0 million as of FY2024, which was up 322.91% from $1.4 million recorded in FY2023.
  • In the past 5 years, Dianthus Therapeutics' Amortizatization of Intangibles ranged from a high of $6.0 million in FY2024 and a low of -$708,000 during FY2021.
  • Over the past 3 years, Dianthus Therapeutics' median Amortizatization of Intangibles value was $1.4 million (recorded in 2023), while the average stood at $2.7 million.
  • In the last 5 years, Dianthus Therapeutics' Amortizatization of Intangibles plummeted by 295.53% in 2021 and then surged by 322.91% in 2024.
  • Over the past 5 years, Dianthus Therapeutics' Amortizatization of Intangibles (Yearly) stood at -$179,000 in 2020, then tumbled by 295.53% to -$708,000 in 2021, then surged by 185.59% to $606,000 in 2022, then skyrocketed by 134.82% to $1.4 million in 2023, then surged by 322.91% to $6.0 million in 2024.